Mirtazapin ist kein guter Therapiebooster
- PMID: 30542867
- DOI: 10.1007/s15006-018-1228-z
Mirtazapin ist kein guter Therapiebooster
Comment on
-
Mirtazapine added to SSRIs or SNRIs for treatment resistant depression in primary care: phase III randomised placebo controlled trial (MIR).BMJ. 2018 Oct 31;363:k4218. doi: 10.1136/bmj.k4218. BMJ. 2018. PMID: 30381374 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
